Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.8337 per EA under NDC 68084054921. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
American Health PackagingNDC
68084054921
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018163FDA Approved
Before 1982
TE Code
AB
On Market Since
8/1/2012
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 81.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8337 per EA |
|---|---|
| All-time high | $5.1228 (Sep 10, 2014) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9537 |
| 52-week low | $0.7894 |
| Median price | $1.7309 |
| Average price | $2.2300 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Temazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by American Health Packaging, is $0.8337 per EA (NDC 68084054921), effective Sep 30, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has declined 81.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $5.1228 (Sep 10, 2014), with a median of $1.7309 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 7.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 68084054921) is labeled by American Health Packaging, and CMS classifies it as a generic product.